These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
44. Techniques for the neurological examination of taxane-induced neuropathy. Ohsumi S; Sunada Y Breast Cancer; 2004; 11(1):86-91. PubMed ID: 14718799 [TBL] [Abstract][Full Text] [Related]
45. New data question treatment for oxaliplatin neurotoxicity. Wolf SL Clin J Oncol Nurs; 2008 Feb; 12(1):14; author reply 14. PubMed ID: 18323035 [No Abstract] [Full Text] [Related]
46. [The specific features of the development and course of toxicohypoxic encephalopathy in acute poisoning by neurotoxic agents]. Luzhnikov EA; Lezhenina NF; Gol'dfarb IuS; Epifanova NM Anesteziol Reanimatol; 2005; (6):4-8. PubMed ID: 16499096 [TBL] [Abstract][Full Text] [Related]
47. NEUROTOX 24. Proceedings of the 24th International Neurotoxicology Conference, November 11-14, 2007, San Antonio, Texas, USA. Neurotoxicology; 2008 Sep; 29(5):753-898. PubMed ID: 19165908 [No Abstract] [Full Text] [Related]
48. Reversible metronidazole-induced neurotoxicity after 10 weeks of therapy. AlDhaleei W; AlMarzooqi A; Gaber N BMJ Case Rep; 2018 Apr; 2018():. PubMed ID: 29678819 [TBL] [Abstract][Full Text] [Related]
49. Chemotherapy-induced peripheral neurotoxicity in cancer survivors: an underdiagnosed clinical entity? Cavaletti G; Alberti P; Marmiroli P Am Soc Clin Oncol Educ Book; 2015; ():e553-60. PubMed ID: 25993222 [TBL] [Abstract][Full Text] [Related]
52. Minimizing Risk of Cancer Therapeutics. Clark M Phys Med Rehabil Clin N Am; 2018 Nov; 29(4):701-719. PubMed ID: 30293625 [TBL] [Abstract][Full Text] [Related]
54. Environmental etiologies of neurological disorders: scientific, translational and policy implications. Proceedings of the Twenty-Fifth Neurotoxicology Conference. October 12-16, 2008. Rochester, New York, USA. Neurotoxicology; 2009 Sep; 30(5):741-850. PubMed ID: 19822257 [No Abstract] [Full Text] [Related]
55. A harmless high? Sammler EM; Foley PL; Lauder GD; Wilson SJ; Goudie AR; O'Riordan JI Lancet; 2010 Aug; 376(9742):742. PubMed ID: 20801405 [No Abstract] [Full Text] [Related]
56. Progress in peripheral nerve disease research in the last two years. Evans M; Manji H J Neurol; 2013 Dec; 260(12):3188-92. PubMed ID: 24154508 [TBL] [Abstract][Full Text] [Related]
57. [Progress of the mechanism for chemotherapeutic drugs induced neurotoxicity and its clinical treatment research]. Zhang JZ; Zheng WH Zhongguo Zhong Xi Yi Jie He Za Zhi; 2012 Feb; 32(2):286-8. PubMed ID: 22574611 [No Abstract] [Full Text] [Related]
58. Histopathological evaluation of the nervous system in National Toxicology Program rodent studies: a modified approach. Rao DB; Little PB; Malarkey DE; Herbert RA; Sills RC Toxicol Pathol; 2011 Apr; 39(3):463-70. PubMed ID: 21430177 [TBL] [Abstract][Full Text] [Related]
59. Neurophysiological, nerve imaging and other techniques to assess chemotherapy-induced peripheral neurotoxicity in the clinical and research settings. Argyriou AA; Park SB; Islam B; Tamburin S; Velasco R; Alberti P; Bruna J; Psimaras D; Cavaletti G; Cornblath DR; J Neurol Neurosurg Psychiatry; 2019 Dec; 90(12):1361-1369. PubMed ID: 31256000 [TBL] [Abstract][Full Text] [Related]
60. Torvis oculis: occupational roots of behavioral neurotoxicology in the last two centuries and beyond. Lucchini RG; Riva MA; Sironi VA; Porro A Neurotoxicology; 2012 Aug; 33(4):652-9. PubMed ID: 22285145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]